In PARPi‐resistant ovarian cancer cells, the liquid–liquid phase separation (LLPS) of KAT6A reduced the cytotoxic effects of PARPi treatment by releasing PARP1 trapped at the DNA break sites. This evidence concerns the gene PARP1 and ovarian carcinoma.